News Releases

Astellas Statement on U.S. Drug Pricing

For the remainder of 2018, Astellas will not increase any of the company’s drug prices in the United States. Astellas believes that the price of medicines should be a fair reflection of the value they bring to patients, healthcare systems and society as a whole. Astellas looks forward to working with the Department of Health and Human Services (HHS) as the department implements its blueprint to reform the healthcare system and improve access for patients. Astellas remains committed to advancing constructive policies that foster medical innovation while ensuring patients’ access to medicines.

Stay Connected

Get only the email alerts you want.


Media Contacts


For media inquiries and reporter requests, please click here to fill out a request form.

Our communications team will respond to verified media requests within 24-48 hours as appropriate.

If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.


Astellas on Twitter
Download Fact Sheet
Explore U.S. Products